NACDS announces support of new methamphetamine legislation
WASHINGTON A law that would expand the Combat Methamphetamine Epidemic Act of 2005 was introduced last month by Rep. Bart Gordon, D-Tenn. The bill would require distributors of pseudoephedrine products to sell only to self-certified retailers registered with the Drug Enforcement Agency.
It also would require the DEA to create an online database where distributors could check if retailers have certified that staff has been properly trained. The bill also would clarify that a retailer who negligently fails to file self-certifications, as required, can face civil fines.
The National Association of Chain Drug Stores expressed its support of the legislation. “These provisions will help prevent the diversion of pseudoephedrine … products for illegitimate purposes, while still allowing consumers with legitimate needs to access these necessary medications,” stated NACDS president and CEO Steve Anderson in a recent letter to Gordon.
“Even with the 2006 law, our country still has a huge meth problem,” stated Gordon in introducing the legislation, called the Combat Methamphetamine Enhancement Act of 2009. “In Tennessee alone, which leads the Southeast in the number of meth labs, 1,300 labs are expected to be seized by the year’s end. We need to do what we can to further reduce access to meth ingredients — this bill will do just that.”
Rep. Jim Sensenbrenner, R-Wis., is co-sponsor of the bipartisan legislation. “Over the years, the Drug Enforcement Agency has had trouble identifying noncompliant stores — with the number of stores estimated to be in the tens of thousands,” Sensenbrenner said. “This legislation will make it tougher for individuals to make meth, and therefore make it even more difficult to buy meth.”
According to the DEA Web site, 53,989 retailers had self-certified and registered their operations by Oct. 27, 2008, including 27,678 pharmacies and drug stores. The self-certification program includes a documented training program for all employees engaged in the sale of PSE products.
The Combat Methamphetamine Enhancement Act already has passed the Senate with bipartisan support after being introduced by Sen. Dianne Feinstein, D-Calif., in January. The legislation presently is before the House Committee on Energy and Commerce.
Take Care Health Systems expands treatment for skin conditions, minor injuries
NEW YORK News that Take Care Health Systems now offers treatment for skin conditions and minor injuries is further evidence that the retail-based clinic model continues to evolve and implement valuable services to augment patients’ healthcare needs.
With more than 48 million skin examinations conducted each year that result in 3.2 million viral wart procedures and 3.3 million skin tag removals, that is a lot of physician time that can be diverted to those professionals working within Take Care’s 340-plus clinics spread throughout 19 states. For patients, being able to stop by a Take Care Clinic offers a convenient and affordable treatment option.
The same can be said for the other services now offered through Take Care Clinics, such as the treatment of skin irritations (contact dermatitis), the closure of minor cuts with Dermabond and an expanded scope of skin evaluation and treatment for skin infections, injuries and rashes.
It is no secret that the country suffers not only from skyrocketing healthcare costs but also a physician shortage and retail-based clinics continue to demonstrate the important role they play in today’s overburdened healthcare system. Industry observers can be certain that they will continue to see expanded services being offered at clinic operators nationwide.
Confirm Biosciences introduces DrugConfirm test
SAN DIEGO Confirm BioSciences on Friday introduced its new DrugConfirm test, an instant-results test for six different illegal drugs that features push button technology. Once the urine is collected and the button on the cup is pushed, the urine will be held in a secure chamber thus eliminating donor manipulation.
DrugConfirm tests for marijuana, cocaine, opiates (such as heroin), methamphetamines, PCP and amphetamines.
More than 3 million youths between the ages of 12 and 17 used marijuana at least once during the past year, according to Department of Health statistics.
“Today more and more parents have the ability to implement drug testing policies within their households, helping deter their own children from becoming part of this statistic,” the company stated. “DrugConfirm test results are instant, so parents can find out right away whether or not their loved ones are using. They also have the option to send the urine sample to the lab for a confirmation screening for extra validation.”
Two-thirds of parents would ask their teenage son or daughter to take a home drug test as a means of keeping them away from drugs, according to a 2006 survey of 2,064 parents, the company noted.
“Parents are the number one deterrent to a teen’s decision to use drugs,” stated Zeynep Ilgaz, Confirm BioSciences CEO. “Studies have shown that the average age of first drug use is 13; more than one-third of teens have used drugs, including almost one in six middle school students and 30% of their high school counterparts reporting marijuana use; and 13% of high school students report using drugs such as cocaine, crack or ecstasy.”
Suggested retail price for the kit is $23.99, which includes prepaid shipping materials for lab, urinalysis report, lab fee and a free counseling hotline.